Insights

Gathering insights about Covetrus…

Similar companies to Covetrus

Covetrus Tech Stack

Covetrus uses 8 technology products and services including RSS, Genesys, SoapUI, and more. Explore Covetrus's tech stack below.

RSS
Content Management System
Genesys
Customer Experience Management
SoapUI
Data Management Platforms
SAP Hybris
E-commerce Platforms
Informatica
Enterprise
Spring Boot
Frameworks And Libraries
Appium
Testing And Qa
Optimal Workshop
Testing And Qa

Media & News

Covetrus Announces Agreement for Chewy to Acquire SmartEquine
Transaction enables Covetrus to sharpen focus on core business of delivering technology-enabled solutions for veterinarians PORTLAND, Maine , Oct. 30, 2025 /PRNewswire/ -- Covetrus®, a global animal-health technology and services company, today announced that it has entered into a definitive agreement with Chewy, Inc. (NYSE: CHWY) for Chewy to acquire the SmartEquine® business. This transaction enables Covetrus to sharpen its focus on its core business of delivering technology-enabled solutions that help veterinarians improve practice performance and patient care.
Oct 30, 2025 | www.prnewswire.com
Cresilon Announces International Distribution Agreement for VETIGEL with Covetrus
Revolutionary hemostatic gel for veterinary surgeons available in U.K. and across Europe through Veterinary Instrumentation and distribution partners NEW YORK, May 20, 2024 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced it has entered into a distribution agreement for its revolutionary hemostatic gel, VETIGEL®, to be sold directly to veterinary surgeons in the U.K. and throughout Europe through Veterinary Instrumentation (Vi), a leading supplier of professional products to support veterinarians in maintaining animal welfare during surgery. Based in the U.K., Vi is part of the Covetrus animal health family of worldwide businesses. Cresilon's VETIGEL, a plant-based hemostatic gel that instantly stops and controls bleeding, is available online for U.K. veterinary surgeons through Vi's extensive portfolio of surgical and orthopedic instrumentation, joint surgery, and fracture fixation products. In addition to the U.K., VETIGEL will be marketed and distributed to veterinary surgeons throughout Europe and many other countries through Vi's extensive global distribution network. Cresilon's Scientific Services Veterinarian and Fellow of the Royal College of Veterinary Surgeons (FRCVS), Dr. Neil Smith, will be providing online training on VETIGEL to all Vi distribution partners in June. "Our partnership with Veterinary Instrumentation will help us provide more veterinary surgeons with a revolutionary hemostatic gel that significantly improves the standard of care for pets and animals," said Matt Lewis, Vice President of Sales at Cresilon. "VETIGEL has been used by thousands of veterinarians thus far and helps veterinary clinics and animal hospitals save time, reduce operating costs, and improve patient outcomes." Since the product's debut in 2021, veterinary surgeons across North America, Europe, and Asia have increasingly used VETIGEL as the fastest and most effective hemostatic agent when treating animals for traumatic wounds and routine and complex surgical procedures, including dental extractions, liver biopsies, tumor and mass removals, cleft palate repairs, and amputations. To date, the plant-based hemostatic gel for veterinary surgeons has been used in more than 50,000 surgical procedures worldwide. VETIGEL offers veterinary surgeons a safe and efficient way to control animal bleeding across multiple types of bleeds and a wide range of surgical procedures. The veterinary hemostatic agent is made of two plant-based polysaccharides that form an instant mechanical barrier to stop bleeding on contact. Once the bleeding is controlled, VETIGEL can be easily removed without disturbing the underlying clot or left in the body to resorb. The plant-based hemostatic gel is supplied in a pre-filled syringe, is easy-to-use, and requires no preparation or special storage conditions. For more information about VETIGEL, visit www.vetigel.com. About CresilonCresilon® is a Brooklyn-based biotechnology company that develops, manufactures, and markets hemostatic medical devices utilizing the company's proprietary hydrogel technology. The company's plant-based technology has revolutionized the current standard by stopping bleeding in seconds. The company's current and future product lines target veterinary, human trauma, and human surgical applications. Cresilon's mission is to save lives. For more information about Cresilon, which was named to Fast Company's annual list of the World's Most Innovative Companies of 2024, ranking No. 1 in the medical devices category, visit www.cresilon.com.
May 20, 2024 | www.prnewswire.com
CD&R, TPG Take Covetrus Private In $4B Deal
Clayton, Dubilier & Rice (CD&R), a private investment firm, and TPG Capital will acquire animal-health technology and services company Covetrus Inc (NASDAQ: CVET) for $21.00 per share, representing an enterprise value of approximately $4 billion. CD&R and its affiliates.
May 25, 2022 | www.benzinga.com
Covetrus going private in $4 billion deal
Animal health company Covetrus Inc. CVET, -0.20% said Wednesday it agreed to be taken private by Clayton, Dubilier & Rice (CD&R) and TPG Capital TPG, -0.90% in a deal valued at $4 billion. The two private equity firms agreed to pay $21 a share, which is $1.34 or 6.8% over its closing price of $19.66 a share on Tuesday and a 39% premium over its 30-day volume weighted average price per share as of the unaffected stock price as of May 13.
May 25, 2022 | www.marketwatch.com
Covetrus to Be Taken Private for $4 Billion
Private-equity firms CD&R and TPG Capital will pay $21 a share to acquire the veterinary services company.
May 25, 2022 | www.barrons.com
Covetrus Gets Private-Equity Buyout Offer at $21 a Share
CD&R and TPG offer to pay $21 a share in cash for Covetrus, which develops technologies and services for the animal health industry.
May 20, 2022 | www.barrons.com
Covetrus (CVET) Q1 Earnings Surpass Estimates
Covetrus (CVET) delivered earnings and revenue surprises of 8.70% and 0.32%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
May 05, 2022 | www.zacks.com

Covetrus's Email Address Formats

Covetrus uses at least 1 format(s):

Covetrus Email Formats	Example	Percentage
First.Last@covetrus.com	John.Doe@covetrus.com	91%
FirstLast@covetrus.com	JohnDoe@covetrus.com	5%
Last.First@covetrus.com	Doe.John@covetrus.com	3%
FLast@covetrus.com	JDoe@covetrus.com	1%

Frequently Asked Questions

What is Covetrus's stock symbol?

Covetrus is a publicly traded company; the company's stock symbol is CVET.

What is Covetrus's official website and social media links?

Covetrus's official website is covetrus.com and has social profiles on LinkedIn Crunchbase.

What is Covetrus's NAICS code?

Covetrus's NAICS code is 54194 - Veterinary Services.

How many employees does Covetrus have currently?

As of December 2025, Covetrus has approximately 5K employees across 5 continents, including North AmericaEuropeOceania. Key team members include Chief Executive Officer: B. W.Chief Commercial Officer (cco): K. G.Chief Operating Officer - North America: B. N.. Explore Covetrus's employee directory with LeadIQ.

What industry does Covetrus belong to?

Covetrus operates in the Veterinary Services industry.

What technology does Covetrus use?

Covetrus's tech stack includes RSSGenesysSoapUISAP HybrisInformaticaSpring BootAppiumOptimal Workshop.

What is Covetrus's email format?

Covetrus's email format typically follows the pattern of First.Last@covetrus.com. Find more Covetrus email formats with LeadIQ.

Covetrus

Q: What is Covetrus's official website and social media links?

Covetrus's official website is covetrus.com. Covetrus has social profiles on LinkedIn.

Q: How many employees does Covetrus have currently?

Covetrus has approximately 5K employees.

Q: What technology does Covetrus use?

Covetrus's tech stack includes Articulate 360, Adobe Acrobat DC, Spring Cloud, Atlassian, Google Sheets.

Veterinary ServicesMaine, United States5001-10000 Employees

Covetrus is the first tech-enabled veterinary-practice improvement company. Our mission is to drive better financial and clinical outcomes for veterinarians.